Targeted Drug VEGFR2 Inhibitors for NSCLC Market

Targeted Drug VEGFR2 Inhibitors for NSCLC Market Key Drivers and Forecast 2025-2032

26 February 2025Martin

Targeted Drug VEGFR2 Inhibitors for NSCLC Market Trends And Drivers The global Targeted Drug VEGFR2 Inhibitors for Non-Small Cell Lung Cancer (NSCLC) market size was valued at USD 2.6 Billion in 2022 and is projected to reach USD 8.3 Billion by 2030, growing at a CAGR of 15.6% from 2024 to 2030. The increasing prevalence […]